These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 23527919

  • 1. Neutrophil elastase-mediated lung disease.
    Sandhaus RA, Turino G.
    COPD; 2013 Mar; 10 Suppl 1():60-3. PubMed ID: 23527919
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT, Vimalanathan S.
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
    Cavarra E, Martorana PA, Gambelli F, de Santi M, van Even P, Lungarella G.
    Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
    [Abstract] [Full Text] [Related]

  • 4. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG.
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [Abstract] [Full Text] [Related]

  • 5. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
    de Santi MM, Martorana PA, Cavarra E, Lungarella G.
    Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
    [Abstract] [Full Text] [Related]

  • 6. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA, Dijkman JH.
    Ned Tijdschr Geneeskd; 1990 Jun 09; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract] [Full Text] [Related]

  • 7. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD, Crystal RG.
    COPD; 2013 Mar 09; 10 Suppl 1():64-7. PubMed ID: 23527997
    [Abstract] [Full Text] [Related]

  • 8. Alpha-1 antitrypsin deficiency in emphysema.
    Khan H, Salman KA, Ahmed S.
    J Assoc Physicians India; 2002 Apr 09; 50():579-82. PubMed ID: 12164415
    [Abstract] [Full Text] [Related]

  • 9. The role of elastases in the development of emphysema.
    Kuhn C, Senior RM.
    Lung; 1978 Dec 09; 155(1):185-197. PubMed ID: 27709342
    [Abstract] [Full Text] [Related]

  • 10. Neutrophil influx into the lungs of beige mice is followed by elastolytic damage and emphysema.
    Cavarra E, Martorana PA, de Santi M, Bartalesi B, Cortese S, Gambelli F, Lungarella G.
    Am J Respir Cell Mol Biol; 1999 Feb 09; 20(2):264-9. PubMed ID: 9922217
    [Abstract] [Full Text] [Related]

  • 11. Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.
    Guyot N, Wartelle J, Malleret L, Todorov AA, Devouassoux G, Pacheco Y, Jenne DE, Belaaouaj A.
    Am J Pathol; 2014 Aug 09; 184(8):2197-210. PubMed ID: 24929239
    [Abstract] [Full Text] [Related]

  • 12. [Elastase inhibitors].
    Reboud-Ravaux M.
    J Soc Biol; 2001 Aug 09; 195(2):143-50. PubMed ID: 11723826
    [Abstract] [Full Text] [Related]

  • 13. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S.
    Eur Respir J; 1991 Oct 09; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract] [Full Text] [Related]

  • 14. [From gene disease; alpha1-antitrypsine deficiency].
    Hiemstra PS, Stolk J.
    Ned Tijdschr Geneeskd; 2003 Apr 19; 147(16):758-60. PubMed ID: 12731467
    [Abstract] [Full Text] [Related]

  • 15. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C, Reeves EP, McElvaney NG.
    Ann Am Thorac Soc; 2016 Aug 19; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [Abstract] [Full Text] [Related]

  • 16. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G.
    Lab Invest; 1993 Feb 19; 68(2):233-41. PubMed ID: 8441253
    [Abstract] [Full Text] [Related]

  • 17. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H, Stockley RA.
    Curr Opin Pulm Med; 2006 Mar 19; 12(2):125-31. PubMed ID: 16456382
    [Abstract] [Full Text] [Related]

  • 18. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S, Lin YY, He J, Rouhani FN, Brantly M, Turino GM.
    COPD; 2013 Aug 19; 10(4):473-81. PubMed ID: 23560990
    [Abstract] [Full Text] [Related]

  • 19. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG.
    N Engl J Med; 1987 Apr 23; 316(17):1055-62. PubMed ID: 3494198
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B, Ferrarotti I, Miravitlles M.
    Eur Respir J; 2016 Jan 23; 47(1):35-8. PubMed ID: 26721962
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.